gmp reiterates buy, page-22

well spotted rormon. It does not make sense that the fully diluted share nos (2,872m) are less than the share nos (2,993m) in the GMP analysis. I went looking for the last app 3b and cannot find one. They say in last presentation they have 3.1B shares and by my calculation they have 743m in the money options. Divide the PV of equity from GMP report $292m by 3.1 + 0.743m and I get value per fully diluted share of 7.6c.